The initial experience of
            <scp>COVID</scp>
            ‐19 vaccination in autoimmune blistering diseases patients from a reference care center in Italy

Bardazzi, Federico; Abbenante, Diego; Filippi, Federica; Sacchelli, Lidia; Loi, Camilla

doi:10.1111/dth.15057

Search citation statements

Order By: Relevance

Paper Sections

Select...

Dear Editor1

Table1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article1

Relationship

Self Cite1

Independent0

Authors

Journals

Cited by 1 publication

(2 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Interestingly, we did not observe any flare of bullous disease after the first or second dose of anti-COVID-19 vaccination. 4 The pathogenesis should be explained by molecular mimicry between basement membrane-specific proteins (e.g., BP-180 and BP-230) and SARS-CoV-2 spike protein, that is used by the virus to bind and fuse with host cells. 5 Some authors however suggested that the vaccine may induce a great immunological response in individuals with immunological predisposition and consequent production of antibodies 6 ; this explanation match with the two cases observed in patients not previously affected by bullous diseases.…”

Section: Dear Editormentioning

confidence: 99%